<DOC>
	<DOCNO>NCT02203630</DOCNO>
	<brief_summary>Septic shock condition mark severe infection cause hypotension require vasopressor maintain adequate perfusion vital organ . The Surviving Sepsis campaign , international organization form purpose guide management sepsis septic shock , currently recommend norepinephrine first-choice vasopressor septic shock . Phenylephrine , vasopressor FDA-approved use septic shock , recommend alternative vasopressor septic shock complicate tachyarrhythmia mitigate cardiac complication . This recommendation base solely experience scientific evidence support recommendation . The investigator conduct open-label randomized control trial ( RCT ) directly compare phenylephrine norepinephrine , two FDA-approved vasopressor use clinical practice management septic shock . The investigator perform study population patient septic shock complete follow aim : Aim 1 : Determine incidence tachyarrhythmias . Aim 2 : Determine vasopressor , phenylephrine norepinephrine , associate low heart rate . Aim 3 : Determine vasopressor , phenylephrine norepinephrine , associate high incidence new tachyarrhythmias . Aim 4 : Determine vasopressor , phenylephrine norepinephrine , associate less time tachyarrhythmia . Aim 5 : Determine vasopressor , phenylephrine norepinephrine , associate few complication , include cardiac complication . The investigator hypothesize setting , phenylephrine improve management septic shock use `` first choice '' vasopressor : 1 . Decreasing mean heart rate 2 . Decreasing incidence new tachyarrhythmias 3 . Decreasing amount time spend tachyarrhythmia patient develop new onset recurrent tachyarrhythmias 4 . Decreasing number cardiac complication</brief_summary>
	<brief_title>A Pilot Trial Phenylephrine Versus Norepinephrine Septic Shock Critically Ill Patients</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<mesh_term>Vasoconstrictor Agents</mesh_term>
	<criteria>Adults 18 year age great Intention treat vasopressor diagnosis septic shock Exclusion criterion meet Emergent indication surgery Patient possess terminal condition patient medical decision maker decide deescalate medical care ( patient Do Not Resuscitate order standard care continue exclude ) Known allergy phenylephrine norepinephrine Treated vasopressor &gt; 12 hour current episode shock Preference specific vasopressor agent patient 's provider Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Septic shock</keyword>
	<keyword>Vasopressor Agents</keyword>
	<keyword>Phenylephrine</keyword>
	<keyword>Norepinephrine</keyword>
	<keyword>Tachycardia</keyword>
	<keyword>Heart Rate</keyword>
	<keyword>Arrhythmia</keyword>
	<keyword>Catecholamine</keyword>
</DOC>